Nigella sativa (Ranunculaceae) Black Cumin, Black Seed, Kalonji, Fennel Flower

Sep 3

15 min read

Nigella sativa is a plant of extraordinary pharmacological breadth, its small black seeds revered across civilizations for over two millennia. Native to Southwest Asia, this delicate annual has been cultivated since antiquity, its seeds discovered in Tutankhamun's tomb and praised by Avicenna as a remedy for "all diseases except death." The seed is the source of a complex essential oil rich in thymoquinone, a compound that has become the focus of intense modern research. Contemporary studies from 2025 and 2026 are now validating many traditional claims, demonstrating significant immunomodulatory activity, potent antioxidant effects, antimicrobial action against resistant pathogens, and promising results in metabolic syndrome, respiratory disorders, and neuroinflammation. The plant stands as one of the most thoroughly investigated medicinal species in the modern pharmacopoeia, bridging ancient wisdom and cutting-edge science with unusual rigour.

---

1. Taxonomic Insights

Species: Nigella sativa L.

Family: Ranunculaceae (Buttercup Family)

Genus: Nigella

Basionym: Nigella sativa L. (no change; original Linnaean designation)

---

Botanical Description

Nigella sativa is an annual herb, typically reaching 20 to 50 centimetres in height, with an erect, branching stem and finely dissected, feathery foliage. The plant is delicate in appearance but remarkably resilient, tolerating poor soils and dry conditions. It completes its life cycle within three to four months, flowering in late spring and setting seed in summer.

Key Identification Features:

The stem is erect, branched, and slightly grooved, with a pale green colour and sparse, fine hairs. The leaves are alternate, finely dissected, 2 to 4 centimetres long, and divided into narrow, linear segments, giving the plant a lacy, fern-like appearance. The flowers are solitary, terminal, 2 to 3 centimetres in diameter, with five petal-like sepals that are pale blue, white, or pinkish in colour. The petals are reduced to small, nectar-bearing structures, surrounded by numerous stamens. The fruit is a distinctive, inflated capsule, 1 to 2 centimetres long, composed of five to ten fused follicles, each with a horn-like projection at the apex. The capsule turns brown at maturity and dehisces to release numerous small, black, angular seeds, 2 to 3 millimetres long, with a rough, reticulated surface.

Distribution: Native to Southwest Asia, including parts of Turkey, Syria, Iraq, and Iran, and possibly extending into the Mediterranean region and North Africa. It has been cultivated and naturalized throughout the Middle East, South Asia, North Africa, and parts of Europe. It grows from sea level to 1,500 metres elevation.

Conservation Status: Not assessed by the IUCN. The plant is widely cultivated as a spice and medicinal herb and is considered abundant throughout its range. No significant threats to wild populations are documented.

---

Etymology

The generic name Nigella derives from the Latin "niger," meaning black, referring to the dark seeds. The specific epithet sativa comes from the Latin "sativus," meaning sown or cultivated, distinguishing the plant from its wild relatives.

---

2. Common Names

---

3. Related Herbs from the Ranunculaceae Family

Nigella sativa belongs to the Ranunculaceae family, a large and chemically diverse family containing both important medicinal plants and highly toxic species.

Nigella damascena (Love-in-a-Mist): A close relative with similar chemistry but lower thymoquinone content. Used ornamentally and occasionally as a spice substitute, though less potent medicinally.

Hydrastis canadensis (Goldenseal): A member of the same family, valued for its antimicrobial alkaloid berberine and used for digestive and respiratory infections.

Coptis chinensis (Chinese Goldthread): Another berberine-containing relative, used in traditional Chinese medicine for gastrointestinal infections and inflammation.

Aconitum napellus (Monkshood): A highly toxic member of the family, illustrating the chemical diversity and potential danger within the Ranunculaceae.

Cimicifuga racemosa (Black Cohosh): A related species used for menopausal symptoms and inflammatory conditions.

---

4. Medicinal Uses: Summary of Primary and Secondary Actions

Primary Actions:

Immunomodulatory: Thymoquinone and related compounds modulate immune function by balancing Th1/Th2 responses, enhancing natural killer cell activity, and reducing excessive inflammation. Clinical studies demonstrate improved immune parameters in various conditions.

Antioxidant: The seed and its oil exhibit potent free radical scavenging activity, attributed primarily to thymoquinone, which upregulates endogenous antioxidant enzymes including superoxide dismutase, catalase, and glutathione peroxidase.

Anti-inflammatory: Thymoquinone inhibits NF-κB signalling, reducing production of pro-inflammatory cytokines including TNF-α, IL-1β, IL-6, and COX-2. Clinical trials demonstrate efficacy in rheumatoid arthritis, allergic rhinitis, and inflammatory skin conditions.

Antimicrobial: Seed extracts and essential oil show activity against a broad spectrum of bacteria, fungi, and viruses, including methicillin-resistant Staphylococcus aureus (MRSA), Candida species, and certain viral pathogens.

Bronchodilator and Antitussive: Clinical studies demonstrate improvement in asthma symptoms, pulmonary function, and cough severity, supporting traditional use for respiratory disorders.

Secondary Actions:

Antidiabetic: Clinical trials show significant reductions in fasting blood glucose, HbA1c, and insulin resistance in type 2 diabetes.

Hypolipidemic: Studies demonstrate reductions in total cholesterol, LDL cholesterol, and triglycerides, with modest increases in HDL cholesterol.

Hepatoprotective: Animal and human studies show protection against liver injury and improvement in non-alcoholic fatty liver disease.

Anticancer: Thymoquinone has demonstrated cytotoxic and pro-apoptotic effects against multiple cancer cell lines in vitro and in animal models.

Gastroprotective: Studies show protection against gastric ulcers and improvement in Helicobacter pylori eradication when combined with standard therapy.

Antihypertensive: Clinical trials demonstrate modest reductions in blood pressure in hypertensive patients.

---

Medicinal Parts

The seeds are the primary medicinal part, used whole, ground, pressed for oil, or extracted for thymoquinone.

Seeds: The primary medicinal part. Contain the highest concentration of thymoquinone and related compounds. Used as a spice, in infusions, decoctions, and as the source of the essential oil.

Seed Oil: Extracted by cold pressing. Rich in thymoquinone, fatty acids, and other bioactive compounds. Used orally and topically.

Aerial Parts: Occasionally used in traditional medicine, though less commonly than the seeds. Contain lower concentrations of active compounds.

---

5. Phytochemistry

5.1 Quinones and Related Compounds

The defining chemical class of Nigella sativa, responsible for much of its pharmacological activity.

Thymoquinone: The principal bioactive compound, comprising 30 to 48 percent of the essential oil. A monoterpene quinone with potent antioxidant, anti-inflammatory, immunomodulatory, antimicrobial, and anticancer properties. It acts through modulation of NF-κB, Nrf2, and other key signalling pathways.

Thymohydroquinone: A reduced form of thymoquinone, present in lower concentrations, with similar but less potent biological activity.

Dithymoquinone: A dimeric form with antioxidant and anti-inflammatory activity.

Nigellone: A polymeric carbonyl compound with bronchodilator and antihistamine properties, contributing to the antiasthmatic effects.

5.2 Alkaloids

Nigellicine: An indazole alkaloid with anti-inflammatory and antioxidant activity.

Nigellidine: Another indazole alkaloid, structurally related to nigellicine, with similar biological properties.

Nigellimine: An isoquinoline alkaloid with antimicrobial activity.

5.3 Fatty Acids

Linoleic Acid: A polyunsaturated omega-6 fatty acid, comprising 50 to 60 percent of the fixed oil.

Oleic Acid: A monounsaturated fatty acid, comprising 20 to 25 percent of the fixed oil.

Palmitic Acid: A saturated fatty acid, comprising 10 to 12 percent of the fixed oil.

5.4 Other Compounds

Saponins: Triterpenoid saponins, including α-hederin, contribute to antimicrobial and cytotoxic activity.

Flavonoids: Various flavonoids, including quercetin and kaempferol, contribute to antioxidant activity.

Phenolic Acids: Chlorogenic acid and related compounds are present in moderate concentrations.

Sterols: β-Sitosterol and related phytosterols contribute to hypocholesterolemic activity.

---

6. Mechanisms of Action

6.1 Immunomodulatory Activity: NF-κB Inhibition and Cytokine Modulation

Thymoquinone is a potent modulator of immune function. It inhibits the activation of NF-κB, a transcription factor that regulates the expression of numerous pro-inflammatory genes. By preventing the translocation of NF-κB to the nucleus, thymoquinone reduces the production of TNF-α, IL-1β, IL-6, and other inflammatory cytokines. Simultaneously, it enhances the activity of natural killer cells and cytotoxic T lymphocytes, strengthening the body's defence against infection and malignancy. This dual action, suppressing excessive inflammation while enhancing protective immunity, underlies the plant's reputation as an immunomodulator.

6.2 Antioxidant Activity: Nrf2 Activation and Free Radical Scavenging

Thymoquinone acts as a direct free radical scavenger and as an indirect antioxidant through activation of the Nrf2 signalling pathway. Nrf2 is a transcription factor that controls the expression of endogenous antioxidant enzymes, including superoxide dismutase, catalase, glutathione peroxidase, and heme oxygenase-1. By activating Nrf2, thymoquinone upregulates these enzymes, providing sustained protection against oxidative stress. This mechanism is central to the hepatoprotective, cardioprotective, and neuroprotective effects.

6.3 Anti-inflammatory Activity: COX-2 and 5-LOX Inhibition

Thymoquinone inhibits both cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX), key enzymes in the synthesis of prostaglandins and leukotrienes. This dual inhibition reduces the production of inflammatory mediators, providing relief from pain, swelling, and other symptoms of inflammation. The mechanism is similar to that of non-steroidal anti-inflammatory drugs, but with a more favourable safety profile.

6.4 Antimicrobial Activity: Membrane Disruption and Enzyme Inhibition

Thymoquinone and related compounds disrupt microbial cell membranes, increasing permeability and causing leakage of intracellular contents. They also inhibit essential microbial enzymes, including those involved in cell wall synthesis and DNA replication. The essential oil is active against a broad spectrum of bacteria, including antibiotic-resistant strains, as well as fungi and certain viruses.

6.5 Anticancer Activity: Apoptosis Induction and Cell Cycle Arrest

Thymoquinone induces apoptosis in cancer cells through multiple mechanisms. It activates the intrinsic apoptotic pathway by increasing the ratio of pro-apoptotic to anti-apoptotic Bcl-2 family proteins, leading to mitochondrial membrane permeabilization and caspase activation. It also causes cell cycle arrest at the G1/S and G2/M checkpoints, preventing cancer cell proliferation. Additionally, thymoquinone inhibits angiogenesis and metastasis by modulating vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs).

---

7. Traditional and Ethnobotanical Uses

7.1 Respiratory Disorders

Formulation: Seed infusion, seed powder, or oil.

Preparation and Use: A decoction of the seeds is consumed for asthma, bronchitis, cough, and respiratory congestion. The oil is sometimes applied topically to the chest as a rubefacient and expectorant. In traditional Arabic medicine, the seeds are considered a primary remedy for respiratory complaints.

Scientific Validation: Multiple clinical trials demonstrate significant improvement in asthma symptoms, pulmonary function, and cough severity with Nigella sativa supplementation. The bronchodilator and anti-inflammatory effects are well documented.

---

7.2 Digestive Disorders

Formulation: Seed powder, infusion, or oil.

Preparation and Use: The seeds are consumed to relieve indigestion, flatulence, diarrhoea, and intestinal parasites. The oil is used to treat gastric ulcers and Helicobacter pylori infection.

Scientific Validation: Studies demonstrate gastroprotective effects, reduction in H. pylori colonization, and improvement in dyspepsia symptoms.

---

7.3 Metabolic Disorders

Formulation: Seed powder or oil.

Preparation and Use: Traditional systems across the Middle East and South Asia use the seeds for diabetes, high cholesterol, and obesity. The seeds are consumed with food or as a decoction.

Scientific Validation: Multiple clinical trials demonstrate significant reductions in fasting blood glucose, HbA1c, total cholesterol, LDL cholesterol, and triglycerides.

---

7.4 Skin Disorders

Formulation: Seed oil or paste.

Preparation and Use: The oil is applied topically for eczema, psoriasis, acne, and wound healing. A paste of ground seeds is used for boils, abscesses, and skin infections.

Scientific Validation: Studies demonstrate antimicrobial, anti-inflammatory, and wound-healing properties, supporting these traditional applications.

---

7.5 Regional Ethnomedicinal Applications Summary

Middle East: The seeds are a foundational remedy in Arabic medicine, known as "habbat al-barakah" or "the blessed seed." Used for respiratory, digestive, metabolic, and immune disorders.

South Asia: In Ayurveda and Unani medicine, kalonji is used for a wide range of conditions, including asthma, digestive complaints, and skin diseases.

North Africa: Used traditionally for respiratory infections, digestive disorders, and as a general tonic.

Europe: Historically used as a spice and medicinal herb, particularly for respiratory and digestive complaints.

---

8. Healing Recipes, Teas, Decoctions, and Practical Applications

8.1 Seed Decoction for Respiratory Health

Purpose: To relieve asthma, bronchitis, and cough.

Preparation and Use: Take one teaspoon of whole Nigella sativa seeds. Boil in 250 millilitres of water for ten minutes. Strain and drink one cup two to three times daily. The decoction has a mild, peppery taste.

Scientific Validation: Clinical trials demonstrate improvement in asthma symptoms and pulmonary function. The preparation is safe for short-term use.

---

8.2 Seed Powder for Metabolic Health

Purpose: To help manage blood sugar and cholesterol.

Preparation and Use: Take half a teaspoon of freshly ground Nigella sativa seeds. Consume with water or mix into food twice daily. Alternatively, take one teaspoon of cold-pressed seed oil daily.

Scientific Validation: Multiple clinical trials demonstrate reductions in fasting blood glucose, HbA1c, and lipid parameters with Nigella sativa supplementation.

---

8.3 Seed Oil for Skin Conditions

Purpose: To treat eczema, psoriasis, and acne.

Preparation and Use: Apply cold-pressed Nigella sativa oil directly to the affected area twice daily. For acne, apply a thin layer after cleansing. For eczema and psoriasis, massage gently into the skin.

Scientific Validation: Studies demonstrate antimicrobial, anti-inflammatory, and wound-healing properties. The topical use is safe and well tolerated.

---

8.4 Seed Paste for Joint Pain

Purpose: To relieve inflammatory joint pain.

Preparation and Use: Grind one tablespoon of Nigella sativa seeds into a paste with a small amount of warm water. Apply to the painful joint and cover with a clean cloth for thirty minutes. Repeat twice daily.

Scientific Validation: Anti-inflammatory activity is well documented. Topical application provides local relief.

---

8.5 Culinary Uses and Nutritional Information

Nigella sativa seeds are widely used as a spice, particularly in Middle Eastern, South Asian, and North African cuisines. They are sprinkled on breads (such as naan and pide), added to curries, pickles, and vegetable dishes, and used to flavour cheeses and pastries. The flavour is pungent, slightly bitter, and reminiscent of oregano with notes of onion and black pepper. Nutritionally, the seeds are rich in protein (20 to 25 percent), healthy fats (30 to 35 percent), and fibre, with significant amounts of iron, calcium, and B vitamins.

---

9. Clinical Significance and Evidence Summary

9.1 Evidence Hierarchy by Activity

Immunomodulatory: Strong evidence from in vitro studies, animal models, and human clinical trials. Multiple randomized controlled trials demonstrate immune-modulating effects in various conditions.

Antioxidant: Strong evidence from in vitro assays, animal studies, and human trials demonstrating increased antioxidant enzyme activity and reduced oxidative stress markers.

Anti-inflammatory: Strong evidence from clinical trials in rheumatoid arthritis, allergic rhinitis, and inflammatory skin conditions.

Antidiabetic: Strong evidence from multiple randomized controlled trials demonstrating significant reductions in blood glucose and HbA1c.

Hypolipidemic: Strong evidence from clinical trials demonstrating improvements in lipid profiles.

Bronchodilator: Strong evidence from clinical trials in asthma demonstrating improvement in pulmonary function and symptom scores.

Antimicrobial: Moderate to strong evidence from in vitro studies. Clinical data are limited but promising, particularly for H. pylori and oral pathogens.

Anticancer: Moderate evidence from in vitro and animal studies. Human clinical trials are limited and ongoing.

---

9.2 Clinical Trial Data

Nigella sativa is one of the most extensively studied medicinal plants in human clinical trials. Over 100 randomized controlled trials have been conducted, covering conditions including asthma, allergic rhinitis, type 2 diabetes, dyslipidemia, hypertension, rheumatoid arthritis, non-alcoholic fatty liver disease, and Helicobacter pylori infection. A meta-analysis of clinical trials in type 2 diabetes (2020) found significant reductions in fasting blood glucose (mean difference -14.9 mg/dL), HbA1c (mean difference -0.7 percent), and insulin resistance. Another meta-analysis of trials in dyslipidemia (2021) found significant reductions in total cholesterol, LDL cholesterol, and triglycerides.

---

9.3 Safety and Toxicology Data

Nigella sativa is generally recognized as safe when consumed in moderate amounts as a spice or short-term supplement. Clinical trials using doses of 1 to 3 grams of seed or 1 to 3 millilitres of oil daily for up to 12 weeks reported no serious adverse effects. The oral LD50 of thymoquinone in rats is approximately 2.4 grams per kilogram, indicating low acute toxicity. Long-term safety data are limited, and high doses may cause gastrointestinal discomfort, dizziness, or allergic reactions in sensitive individuals.

---

10. Safety and Toxicology

10.1 Toxicity Profile

Acute Toxicity: Low. The oral LD50 of the seed extract and thymoquinone in animal models is high, indicating a wide safety margin.

Chronic Toxicity: No significant chronic toxicity has been reported at typical therapeutic doses. Studies in animals using high doses for extended periods show minimal adverse effects.

Clinical Safety: The plant is safe for most adults when consumed in moderate amounts for short to medium-term use. Long-term safety data beyond 12 weeks are limited.

10.2 Contraindications and Precautions

Pregnancy: Contraindicated. The seeds have been traditionally used to induce abortion and may stimulate uterine contractions. Avoid during pregnancy.

Lactation: Limited safety data. Use with caution or avoid.

Children: Use in small amounts as a spice is safe. Medicinal doses should be used with caution and under professional supervision.

Bleeding Disorders: Thymoquinone may inhibit platelet aggregation. Individuals with bleeding disorders or those taking anticoagulant medications should use with caution.

Surgery: Discontinue use at least two weeks before scheduled surgery due to potential effects on bleeding and blood pressure.

10.3 Potential Drug Interactions

Anticoagulants and Antiplatelet Drugs (Warfarin, Aspirin, Clopidogrel): The mechanism involves additive inhibition of platelet aggregation. The clinical significance is increased bleeding risk. Monitor INR and platelet function if used concurrently.

Antidiabetic Medications (Metformin, Sulphonylureas, Insulin): The mechanism involves additive glucose-lowering effects. The risk is hypoglycaemia. Monitor blood glucose and consider reducing antidiabetic medication doses.

Antihypertensive Medications: The plant may potentiate blood pressure-lowering effects. Monitor blood pressure and adjust medication doses accordingly.

Cytochrome P450 Substrates: Thymoquinone may inhibit CYP2C9, CYP2D6, and CYP3A4, potentially affecting the metabolism of various drugs. Clinical significance is unclear.

---

11. Quality Control Parameters

11.1 Marker Compounds for Standardisation

Key compounds suitable as quality markers include thymoquinone, thymohydroquinone, and total essential oil content. For seed oil, fatty acid composition (linoleic, oleic, and palmitic acid ratios) serves as an additional marker.

11.2 Recommended Analytical Methods

High-performance liquid chromatography (HPLC) with UV or mass spectrometry detection is used for quantification of thymoquinone and related compounds. Gas chromatography with mass spectrometry (GC-MS) is recommended for essential oil and fatty acid analysis.

11.3 Suggested Specifications

For seed material: thymoquinone content should be specified and consistent between batches, typically ranging from 0.1 to 0.4 percent in dried seeds. For seed oil: thymoquinone content should be specified, and fatty acid composition should be verified. Total essential oil content should be greater than 0.5 percent in quality seed material.

---

12. Cultivation and Sustainability

12.1 Growth Requirements

Climate: Temperate to subtropical. Prefers warm, dry conditions with full sun.

Habitat: Open, sunny locations with well-drained soil. Tolerates poor soils and drought.

Altitude: Grows from sea level to 1,500 metres.

Soil: Prefers well-drained, sandy or loamy soils. Tolerates a wide range of soil types and pH levels.

Propagation: By seed. Seeds germinate readily in spring and require no specific pre-treatment.

12.2 Sustainable Harvesting

Plant parts harvested: Seeds.

Harvesting method: The capsules are cut when mature and brown, dried, and threshed to release the seeds.

Season: Harvest occurs in late summer.

Caution: Source from reputable suppliers to ensure quality and avoid adulteration with other Nigella species or similar-looking seeds.

12.3 Conservation Status

Not threatened. Nigella sativa is widely cultivated as a spice and medicinal herb throughout its range and beyond. The species is not a conservation concern.

---

13. Cultivar and Varietal Comparison

Nigella sativa shows moderate morphological variation across its range, with several local landraces and improved cultivars.

Turkish Types: Known for high thymoquinone content and strong flavour, preferred for medicinal use.

Indian Types: Selected for seed yield and adaptability to subtropical conditions.

Ethiopian Types: Valued for their distinct aroma and used primarily as a spice.

The thymoquinone content varies significantly between varieties and growing conditions, ranging from 0.1 to 0.4 percent in dried seeds. Breeding programs have focused on increasing thymoquinone content and seed yield.

---

14. Research Gaps and Future Directions

14.1 Critical Research Gaps

Long-term Safety: Clinical trials longer than 12 weeks are lacking. Long-term safety data are needed to support chronic use.

Pharmacokinetics: The absorption, distribution, metabolism, and excretion of thymoquinone in humans are incompletely characterized.

Standardised Formulations: Development of standardised extracts with defined thymoquinone content is needed for consistent clinical use.

Anticancer Clinical Trials: While preclinical evidence is extensive, human clinical trials are limited and require expansion.

Drug Interaction Studies: Systematic evaluation of potential interactions with commonly prescribed medications is needed.

14.2 Future Research Priorities

Oncology: Phase I and II clinical trials of thymoquinone and standardised Nigella sativa extracts in various cancer types.

Neurodegeneration: Investigation of thymoquinone's neuroprotective effects in Alzheimer's disease, Parkinson's disease, and multiple sclerosis.

COVID-19 and Viral Infections: Studies of the antiviral and immunomodulatory effects in viral respiratory infections.

Microbiome: Research on the effects of Nigella sativa on gut microbiota composition and function.

---

15. Commercial Applications

15.1 Nutraceutical Industry

Nigella sativa is a major nutraceutical ingredient, available as seed, oil, and standardised extract. Products are marketed for immune support, metabolic health, respiratory function, and general wellness.

15.2 Pharmaceutical Development

Thymoquinone and related compounds are under investigation as lead compounds for drug development in oncology, inflammatory diseases, and neurodegenerative conditions.

15.3 Food and Spice Industry

The seeds are widely used as a spice in Middle Eastern, South Asian, and North African cuisines. The oil is used in specialty food products.

15.4 Cosmetic Industry

The oil is used in cosmetic formulations for its antioxidant, anti-inflammatory, and antimicrobial properties, particularly in products for acne-prone and sensitive skin.

---

16. Related Plants for Further Study

Nigella damascena (Love-in-a-Mist): A close relative with similar chemistry but lower thymoquinone content. Used ornamentally and occasionally as a spice.

Hydrastis canadensis (Goldenseal): A member of the same family, valued for its antimicrobial alkaloid berberine.

Coptis chinensis (Chinese Goldthread): Another berberine-containing relative, used in traditional Chinese medicine.

Cimicifuga racemosa (Black Cohosh): A related species used for menopausal symptoms and inflammatory conditions.

Curcuma longa (Turmeric): While not in the same family, turmeric shares significant pharmacological overlap with Nigella sativa, including anti-inflammatory and antioxidant properties, and is often combined with black seed in traditional formulations.

---

17. Reference Literature

Primary Research

Clinical trial meta-analysis in type 2 diabetes (2020) demonstrates significant reductions in fasting blood glucose, HbA1c, and insulin resistance with Nigella sativa supplementation.

Clinical trial meta-analysis in dyslipidemia (2021) demonstrates significant improvements in lipid profiles.

Asthma clinical trial (2018) demonstrates significant improvement in asthma control, pulmonary function, and symptom scores with Nigella sativa supplementation.

Thymoquinone pharmacology review (2019) comprehensively documents the antioxidant, anti-inflammatory, immunomodulatory, antimicrobial, and anticancer mechanisms of thymoquinone.

Rheumatoid arthritis clinical trial (2016) demonstrates significant improvement in disease activity scores and inflammatory markers with Nigella sativa oil supplementation.

Hepatoprotective study (2024) demonstrates protective effects against non-alcoholic fatty liver disease in clinical and preclinical models.

Key Monographs and Floras

Flora of Turkey: Provides comprehensive botanical descriptions and distribution data for the species.

The Wealth of India: Documents traditional uses and pharmacological data for the species.

Handbook of Medicinal Herbs: Documents traditional uses and pharmacological data.

Pharmacopoeial Standards: Various national pharmacopoeias include monographs for Nigella sativa seed and oil.

---

18. Disclaimer

Nigella sativa is generally recognized as safe when consumed in moderate amounts as a spice or short-term supplement. Use with appropriate caution during pregnancy and in individuals with bleeding disorders or those taking anticoagulant, antidiabetic, or antihypertensive medications.

This information is for educational and academic purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Pregnant or nursing women should consult a healthcare professional before use.

Individuals on medication, especially anticoagulants, antidiabetics, and antihypertensives, should consult a qualified healthcare practitioner before use.

Do not discontinue prescribed medications without consulting your doctor.

Always consult a qualified healthcare practitioner before using any plant for medicinal purposes.

PREHEALING

Nigella sativa (Ranunculaceae) Black Cumin, Black Seed, Kalonji, Fennel Flower

Related Posts

Comments